Medical devices maker Poly Medicure reported a mixed set of Q4 FY26 earnings on May 25, 2026, as strong revenue growth was overshadowed by pressure on profitability and margins. Following the earnings announcement, investors closely tracked the company’s operational performance amid rising costs and softer margins.
Poly Medicure posted a consolidated net profit of ₹66.3 crore in Q4 FY26, marking a decline of 27.8% compared to ₹91.8 crore reported in the corresponding quarter last year. The sharp fall in profit came despite healthy growth in topline performance.
Revenue from operations rose 21.3% year-on-year to ₹535 crore against ₹441 crore in Q4 FY25, reflecting continued demand across its medical devices and healthcare product portfolio.
However, EBITDA declined 7.4% to ₹110 crore from ₹119 crore in the year-ago period. EBITDA margin also contracted sharply to 20.6% from 27% last year, indicating higher operational costs and pressure on profitability during the quarter.
The company’s other income stood at ₹17.8 crore compared to ₹24.3 crore in the same quarter previous year, while tax expenses fell to ₹20.2 crore from ₹31 crore on a YoY basis.